← Eichor
Study identifier: NCT04872660 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET

Condition: Infertility, Female  ·  Sponsor: Shandong University of Traditional Chinese Medicine

PhasePhase 4
Planned participants800
Who can joinFemale, 21 Years to 42 Years
Healthy volunteersNo

About this study

The purpose of this study is to investigate whether oral Gushen Antai pills supplementation for luteal phase support will improve ongoing pregnancy rate in women with normal ovarian reserve in fresh embryo transfer cycles.

This description comes directly from the study's public registry record.

Talk to the study team

Zhen-Gao Sun, M.D.  ·  +86-13708938621  ·  sunzhengao77@126.com

Jing-Yan Song, M.D.  ·  +86-1876580013  ·  hanlingjuzei91@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Affiliated Hospital of Shandong University of Traditional Chinese MedicineJinan, Shandong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04872660